Evidence map›Paper›PMID 40877299›Full record

ArticleScientific reports2025

Natural compounds attenuate combined chromium and arsenic-induced oxidative stress and nephritic apoptosis by activating the Nrf2/Keap1 signaling and associated xenobiotic metabolizing enzymes.

Swapnil Tripathi, Dharati Parmar, Samir Raval, Dhirendra Pratap Singh, Rajendra Palkhade, Rajeev Mishra, Gyanendra Singh

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Swapnil TripathiToxicology Department, Division of Biological Sciences, ICMR-National Institute of Occupational Health, Ahmedabad, 380016, India.
Dharati ParmarToxicology Department, Division of Biological Sciences, ICMR-National Institute of Occupational Health, Ahmedabad, 380016, India.
Samir RavalCollege of Veterinary Science and Animal Husbandry, Kamdhenu University, Sardarkrushinagar, 385506, India.
Dhirendra Pratap SinghToxicology Department, Division of Biological Sciences, ICMR-National Institute of Occupational Health, Ahmedabad, 380016, India.
Rajendra PalkhadeAnimal House Facility, Division of Biological Sciences, ICMR-National Institute of Occupational Health, Ahmedabad, 380016, India.
Rajeev MishraDepartment of Life Sciences & Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur, 208024, India.
Gyanendra SinghToxicology Department, Division of Biological Sciences, ICMR-National Institute of Occupational Health, Ahmedabad, 380016, India. gyancdri@gmail.com.ORCID http://orcid.org/0000-0003-1406-4227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromium (Cr) and arsenic (As) pose a threat to the exposed population, leading to various renal ailments. Although individual toxicity has been well investigated, little is known about their combined effects. In light of the mounting concern over the environmental impact of heavy metals, the current study investigated the potential benefits of the selected nutraceuticals, i.e., biochanin-A (BCA), coenzyme Q10 (CoQ10), and phloretin (PHL) in combined Cr + As intoxicated Swiss albino mice, providing a comprehensive understanding of the mechanism of action. During the two-week investigation, Cr (75 ppm) and As (100 ppm) were given orally to induce renal toxicity, and were simultaneously treated with BCA (50 mg/kg), CoQ10 (10 mg/kg), and PHL (50 mg/kg) intraperitoneally. The Cr + As-treated group showed an increase in kidney somatic index, metal burden, protein carbonylation, and malondialdehyde, along with a decrease in the activity of (superoxide dismutase, catalase, glutathione-S-transferase, reduced glutathione, and total thiol). Furthermore, DNA degradation, histology, and altered SIRT1/Nrf2/HO‑1/NQO1/SOD2/CYP1A1/KEAP1/CAS-8, and CAS-3 gene expressions corroborated the above findings. Alternatively, co-treatment with the selected antioxidants reversed the above mentioned parameters, highlighting the protective effects of these compounds against Cr + As-induced oxidative damage. Nrf2, a key player in this process, is responsible for the activation of the antioxidant response element and subsequent expression of antioxidant enzymes. We further investigated the possible interactions of BCA, CoQ10, and PHL with the antioxidant enzymes/proteins, SIRT1/Nrf2/KEAP1/HO-1/NQO1, using in silico studies. Our study offers new avenues for the future of chronic kidney disease treatment associated with Cr + As-induced exposure, providing a deeper understanding of the role of Nrf2 in this context.

Indexed as

ApoptosisArsenicBiological ProductsChromiumKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oxidative StressSignal TransductionAnimalsAntioxidantsKidneyMaleMiceXenobioticsAntioxidantsArsenicBiological ProductsChromiumKeap1 protein, mouseKelch-Like ECH-Associated Protein 1Nfe2l2 protein, mouseNF-E2-Related Factor 2XenobioticsArsenicBiochanin-AChromiumCoenzyme Q10PhloretinReactive oxygen species

Identifiers

PMID40877299
PMCPMC12394698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.